1. Home
  2. CRDO vs RVMD Comparison

CRDO vs RVMD Comparison

Compare CRDO & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$172.15

Market Cap

32.2B

Sector

Technology

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$139.54

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
RVMD
Founded
2008
2014
Country
Cayman Islands
United States
Employees
N/A
883
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2B
19.2B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CRDO
RVMD
Price
$172.15
$139.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
19
Target Price
$179.62
$140.84
AVG Volume (30 Days)
6.3M
3.7M
Earning Date
06-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
261.11
N/A
EPS
1.62
N/A
Revenue
$436,775,000.00
N/A
Revenue This Year
$210.92
N/A
Revenue Next Year
$57.22
$533.02
P/E Ratio
$107.52
N/A
Revenue Growth
126.34
N/A
52 Week Low
$45.65
$34.00
52 Week High
$213.80
$155.70

Technical Indicators

Market Signals
Indicator
CRDO
RVMD
Relative Strength Index (RSI) 58.93 61.90
Support Level $129.63 $93.39
Resistance Level $176.70 $155.70
Average True Range (ATR) 12.17 7.73
MACD 0.39 -0.46
Stochastic Oscillator 59.47 44.49

Price Performance

Historical Comparison
CRDO
RVMD

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: